We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BTMDW market cap is 54.64M. The company's latest EPS is USD 0.0977 and P/E is 59.37.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 41.97M | 44.49M | 44.84M | 49.26M | 45.56M |
Operating Income | 7.82M | 7.3M | 7.88M | 7.67M | 7.6M |
Net Income | -13.24M | -103.19M | -6.81M | -5.14M | 7.53M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 164.96M | 185.36M |
Operating Income | 0 | -3.32M | -60.72M | 28.66M |
Net Income | 0 | 11.11M | -969k | 3.32M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 109.58M | 111.65M | 119.14M | 139.05M | 149.75M |
Total Liabilities | 219.47M | 169.92M | 202.94M | 212.29M | 201.01M |
Total Equity | -109.89M | -58.27M | -83.81M | -73.24M | -51.27M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 148k | 318.03M | 111.65M | 155.3M |
Total Liabilities | 123k | 340.66M | 169.92M | 191.84M |
Total Equity | 25k | -22.63M | -58.27M | -36.55M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -15.21M | -9.16M | 13M | 19.77M | 19.93M |
Investing | -1.53M | -1.84M | -380k | -21.23M | -21.71M |
Financing | 67.44M | 63.46M | -4.24M | -9.29M | -11.86M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | -1.37M | -9.16M | 26.88M |
Investing | N/A | -317.5M | -1.84M | -2.71M |
Financing | 2k | 319M | 63.46M | -14.38M |
Market Cap | 54.64M |
Price to Earnings Ratio | 59.37 |
Price to Sales Ratio | 1.06 |
Price to Cash Ratio | 2.21 |
Price to Book Ratio | -5.39 |
Dividend Yield | - |
Shares Outstanding | 33.94M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.66 (35.68%) |
Company Name | Biote Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.biote.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions